Comparing Treatments for Malaria in Cambodia
Author Information
Author(s): Jianping Song, Socheat Duong, Tan Bo, Seila Suon, Xu Ying, Ou Fengzhen, Sokunthea Sreng, Sophorn Leap, Zhou Chongjun, Deng Changsheng, Wang Qi, Li Guoqiao
Primary Institution: Research Center for Qinghao (Artemisia annual L.), Guangzhou University of Chinese Medicine, Guangzhou, China
Hypothesis
The study aims to compare the efficacy and safety of three different artemisinin-based treatments for uncomplicated falciparum malaria.
Conclusion
Artemisinin-piperaquine and dihydroartemisinin-piperaquine phosphate are more effective than artemether-lumefantrine for treating malaria in the Cambodia-Thailand border area.
Supporting Evidence
- The 28-day cure rate for artemisinin-piperaquine was 95.1%.
- Dihydroartemisinin-piperaquine phosphate had a cure rate of 98.2%.
- Artemether-lumefantrine had a lower cure rate of 82.4%.
Takeaway
This study looked at three different medicines to treat malaria, and found that two of them worked better than the third one.
Methodology
The study was a randomized controlled trial comparing three treatments in patients with uncomplicated malaria.
Potential Biases
Potential bias in patient selection and treatment allocation.
Limitations
The study was limited to a specific geographic area and may not be generalizable to other regions.
Participant Demographics
Patients aged 7 to 65 years, with a majority over 15 years old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website